Company News

Symptoms and Impact 

Vascular dementia, a common form of cognitive decline in the Philippines, presents a range of symptoms that can significantly impact daily life. This condition, often resulting from reduced blood flow to the brain, manifests in various ways: 

• Slowness of thought, difficulty with planning, and problems with concentration, affecting decision-making and everyday tasks. 
• Changes in mood or behavior, such as depression, anxiety, or apathy, potentially straining relationships and impacting quality of life. 
• Physical symptoms like slurred speech or weakness on one side of the body, often occurring after transient ischemic attacks (TIAs) or strokes, accompanying cognitive decline. 

Conventional Treatments for Vascular Dementia in the Philippines 

• Doctors in the Philippines often prescribe Alzheimer's medications to treat vascular dementia, aiming to improve cognitive function and manage symptoms. 
• Traditional Chinese medicine, including herbal remedies and acupuncture, is commonly used alongside conventional treatments by Filipinos, offering potential complementary options for symptom management and quality of life improvement. 
• The treatment landscape for vascular dementia in the Philippines is evolving, with the recent introduction of Cerebrolysin® by Getz Healthcare Philippines and Ever Pharma, a medication that may help treat cerebrovascular disorders like vascular dementia. Consulting healthcare professionals for personalized treatment plans is essential. 

Emerging Therapies for Cerebrovascular Disorders: Cerebrolysin® in the Philippines 

Innovative Treatment for Vascular Dementia 

Cerebrolysin® is a neuropeptide preparation used to address various cerebrovascular disorders, including vascular dementia and stroke. Research indicates that Cerebrolysin® may offer significant benefits for patients struggling with these conditions. 

Efficacy in Post-Stroke Recovery 

Studies have demonstrated Cerebrolysin's potential in reducing spasticity following stroke and improving functional outcomes. This could be particularly beneficial for patients in the Philippines seeking comprehensive stroke recovery options. The medication's ability to enhance neuroplasticity may contribute to better rehabilitation results. 

Reducing Complications in Acute Stroke 

Early administration of Cerebrolysin® in conjunction with reperfusion therapy has shown promise in reducing hemorrhagic transformation after ischemic stroke. This finding suggests that the medication may play a crucial role in minimizing complications and improving overall outcomes for stroke patients.  

As vascular dementia cases continue to rise in the Philippines, understanding the symptoms and available treatments is crucial. By recognizing early warning signs and seeking prompt medical attention, you can potentially slow the progression of this challenging condition.  

The recent partnership between Getz Healthcare Philippines and Ever Pharma, introducing Cerebrolysin® as a potential option for cerebrovascular disorders, exemplifies the evolving landscape of dementia care. Contact us for more information on Cerebrolysin®. 

Sources: 

• https://www.mayoclinic.org/diseases-conditions/vascular-dementia/symptoms-causes/syc-20378793 
• https://www.hopkinsmedicine.org/health/conditions-and-diseases/dementia/vascular-dementia 
• https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/vascular-dementia 
• https://www.nhs.uk/conditions/vascular-dementia/symptoms/ 
• https://pmc.ncbi.nlm.nih.gov/articles/PMC10894570/ 
• https://pmc.ncbi.nlm.nih.gov/articles/PMC11374729/ 
• https://www.mims.com/philippines/drug/info/cerebrolysin?type=full 
• https://www.explorationpub.com/Journals/ent/Article/100457 
• https://pmc.ncbi.nlm.nih.gov/articles/PMC8438647/ 
• https://www.everpharma.com/products/cerebrolysin/ 
• https://pmc.ncbi.nlm.nih.gov/articles/PMC5652267/